Literature DB >> 25656623

Duration of residency in a non-endemic area and risk of severe malaria in African immigrants.

A Färnert1, K Wyss2, S Dashti3, P Naucler4.   

Abstract

In malaria-endemic areas, adults very rarely succumb to severe malaria, suggesting that immunity to severe disease is life-long under conditions of repeated exposure. To what extent this protection persists in the absence of exposure remains to be established. The aim of this study was to assess whether duration of residency in a malaria-free country affects the risk for severe malaria in immigrants originating from sub-Saharan Africa. We conducted a retrospective chart review of 948 cases of malaria diagnosed in Stockholm, Sweden in 1995-2013. Among 501 adult patients with Plasmodium falciparum (315 of endemic origin and 186 of non-endemic origin, mainly Sweden), 41 (8.2%) had severe malaria according to WHO criteria (including 5% with parasitaemia), 22 (4.4%) had factors prognostic of poor outcome, and 35 (7.0%) were admitted to intensive care. Overall, patient origin did not affect the odds of severe malaria, according to any of these definitions. However, when the immigrants were stratified with regard to their duration of residency in Sweden, the risk of factors prognostic for poor outcome was associated with duration of prior residency in a malaria-free country among patients of endemic origin (p 0.02), and immigrants who had lived for ≥ 15 years in Sweden had a similar risk as non-immune travellers. The results of this explorative study suggest that, although immunity to severe malaria is maintained for several years in African adults, this protection might be lost with time without repeated re-exposure. A larger study, preferably including multiple centres, will be needed to confirm our findings.
Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Exposure; immigrants; immunity; severe malaria; travellers

Mesh:

Year:  2014        PMID: 25656623     DOI: 10.1016/j.cmi.2014.12.011

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  11 in total

Review 1.  Imported Malaria in Countries where Malaria Is Not Endemic: a Comparison of Semi-immune and Nonimmune Travelers.

Authors:  Johannes Mischlinger; Caroline Rönnberg; Míriam J Álvarez-Martínez; Silja Bühler; Małgorzata Paul; Patricia Schlagenhauf; Eskild Petersen; Michael Ramharter
Journal:  Clin Microbiol Rev       Date:  2020-03-11       Impact factor: 26.132

2.  In Silico Prediction of Plasmodium falciparum Cytoadherence Inhibitors That Disrupt Interaction between gC1qR-DBLβ12 Complex.

Authors:  Abdul Hafiz; Rowaida Bakri; Mohammad Alsaad; Obadah M Fetni; Lojain I Alsubaihi; Hina Shamshad
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-31

3.  Frequent malaria illness episodes in two Malawian patients on antiretroviral therapy soon after stopping cotrimoxazole preventive therapy.

Authors:  Wongani Js Nyangulu; Edson Mwinjiwa; Titus H Divala; Randy G Mungwira; Osward Nyirenda; Maxwell Kanjala; Gillian Mbambo; Jane Mallewa; Terrie E Taylor; Matthew B Laurens; Miriam K Laufer; Joep J van Oosterhout
Journal:  Malawi Med J       Date:  2017-03       Impact factor: 0.875

4.  Interactions between climatic changes and intervention effects on malaria spatio-temporal dynamics in Uganda.

Authors:  Julius Ssempiira; John Kissa; Betty Nambuusi; Eddie Mukooyo; Jimmy Opigo; Fredrick Makumbi; Simon Kasasa; Penelope Vounatsou
Journal:  Parasite Epidemiol Control       Date:  2018-04-26

5.  Severity of Plasmodium falciparum and Non-falciparum Malaria in Travelers and Migrants: A Nationwide Observational Study Over 2 Decades in Sweden.

Authors:  Andreas Wångdahl; Katja Wyss; Dashti Saduddin; Matteo Bottai; Elsie Ydring; Tomas Vikerfors; Anna Färnert
Journal:  J Infect Dis       Date:  2019-09-13       Impact factor: 5.226

6.  Changing plasma cytokine, chemokine and growth factor profiles upon differing malaria transmission intensities.

Authors:  Ruth Aguilar; Joseph J Campo; Silvia Chicuecue; Pau Cisteró; Alba Català; Leopoldina Luis; Itziar Ubillos; Beatriz Galatas; Pedro Aide; Caterina Guinovart; Gemma Moncunill; Carlota Dobaño
Journal:  Malar J       Date:  2019-12-05       Impact factor: 2.979

7.  Genetic diversity and transmissibility of imported Plasmodium vivax in Qatar and three countries of origin.

Authors:  Mohammed H Abdelraheem; Devendra Bansal; Mohammed A Idris; Moawia M Mukhtar; Muzamil M Abdel Hamid; Zainb S Imam; Sisay Getachew; Rakesh Sehgal; Hargobinder Kaur; Amal H Gadalla; Salam Al-Hamidhi; Zainab Al-Hashami; Ali Al-Jabri; Ali A Sultan; Hamza A Babiker
Journal:  Sci Rep       Date:  2018-06-11       Impact factor: 4.379

8.  Assessment of parasite clearance following treatment of severe malaria with intravenous artesunate in Ugandan children enrolled in a randomized controlled clinical trial.

Authors:  Pauline Byakika-Kibwika; Patience Nyakato; Mohammed Lamorde; Agnes N Kiragga
Journal:  Malar J       Date:  2018-10-30       Impact factor: 2.979

9.  Sickle cell disease and malaria: decreased exposure and asplenia can modulate the risk from Plasmodium falciparum.

Authors:  Richard O Mwaiswelo; William Mawala; Per O Iversen; Mariane de Montalembert; Lucio Luzzatto; Julie Makani
Journal:  Malar J       Date:  2020-04-25       Impact factor: 2.979

10.  Obesity and Diabetes as Risk Factors for Severe Plasmodium falciparum Malaria: Results From a Swedish Nationwide Study.

Authors:  Katja Wyss; Andreas Wångdahl; Maria Vesterlund; Ulf Hammar; Saduddin Dashti; Pontus Naucler; Anna Färnert
Journal:  Clin Infect Dis       Date:  2017-09-15       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.